ScholarIQanswers from OpenAlex & ORCID
Dennie T. Frederick
ResearcherPublications, citations & collaboration network
Dennie T. Frederick is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dennie T. Frederick have?
ScholarIQindexed works
Dennie T. Frederick has 533 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dennie T. Frederick have?
ScholarIQcitation count
Dennie T. Frederick has 31,973 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dennie T. Frederick?
ScholarIQh-index
Dennie T. Frederick has an h-index of 66 in OpenAlex.
What is the i10-index of Dennie T. Frederick?
ScholarIQi10-index
Dennie T. Frederick has an i10-index of 110 in OpenAlex.
What is the ORCID of Dennie T. Frederick?
ScholarIQorcid
The ORCID for Dennie T. Frederick is on the source record.
What is the OpenAlex record for Dennie T. Frederick?
ScholarIQopenalex
The OpenAlex for Dennie T. Frederick is on the source record.
What are the most-cited papers on Dennie T. Frederick?
ScholarIQmost cited works
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh, Benjamin Izar, Sanjay M. Prakadan, Marc H. Wadsworth, Daniel J. Treacy, John J. Trombetta, Asaf Rotem, Christopher Rodman, Christine G. Lian, Gëorge F. Murphy, Mohammad Fallahi‐Sichani, Ken Dutton‐Regester, Jia‐Ren Lin, Ofir Cohen, Parin Shah, Diana Lu, Alex S. Genshaft, Travis K. Hughes, Carly G.K. Ziegler, Samuel W. Kazer, Aleth Gaillard, Kellie E. Kolb, Alexandra–Chloé Villani, Cory M. Johannessen, Aleksandr Andreev, Eliezer M. Van Allen, Monica M. Bertagnolli, Peter K. Sorger, Ryan J. Sullivan, Keith T. Flaherty, Dennie T. Frederick, Judit Jané‐Valbuena, Charles H. Yoon, Orit Rozenblatt–Rosen, Alex K. Shalek, Aviv Regev, Levi A. Garraway
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell W. Jenkins, David Lieb, Jonathan Chen, Dennie T. Frederick, Michal Barzily-Rokni, Samuel S. Freeman, Alexandre Reuben, Paul Hoover, Alexandra–Chloé Villani, Elena V. Ivanova, Andrew Portell, Patrick H. Lizotte, Amir Reza Aref, Jean-Pierre Eliane, Marc R. Hammond, Hans Vitzthum, Shauna Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, Zachary A. Cooper, Cloud P. Paweletz, David A. Barbie, Anat Stemmer‐Rachamimov, Keith T. Flaherty, Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller, Michal Barzily-Rokni, Tal Danino, Oliver Jonas, Noam Shental, Deborah Nejman, Nancy Gavert, Yaara Zwang, Zachary A. Cooper, Kevin Shee, Christoph A. Thaiss, Alexandre Reuben, Jonathan Livny, Roi Avraham, Dennie T. Frederick, Matteo Ligorio, Kelly Chatman, Stephen Johnston, Carrie M. Mosher, Alexander Brandis, Garold Fuks, Candice R. Gurbatri, Vancheswaran Gopalakrishnan, Michael P. Kim, Mark W. Hurd, Matthew H. G. Katz, Jason B. Fleming, Anirban Maitra, David A. Smith, Matt Skalak, Jeffrey Bu, Monia Michaud, Sunia A. Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T. Flaherty, Anna Mandinova, Wendy S. Garrett, Sarah P. Thayer, Cristina R. Ferrone, Curtis Huttenhower, Sangeeta N. Bhatia, Dirk Gevers, Jennifer A. Wargo, Todd R. Golub, Ravid Straussman
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco, Christopher Rodman, Mei-Ju Su, Johannes C. Melms, Rachel Leeson, Abhay Kanodia, Shaolin Mei, Jia‐Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Gao Zhang, Claire Margolais, Orr Ashenberg, Patrick A. Ott, Elizabeth I. Buchbinder, Rizwan Haq, F. Stephen Hodi, Genevieve M. Boland, Ryan J. Sullivan, Dennie T. Frederick, Benchun Miao, Tabea Moll, Keith T. Flaherty, Meenhard Herlyn, Russell W. Jenkins, Rohit Thummalapalli, Monika S. Kowalczyk, Israel Cañadas, Bastian Schilling, Adam N.R. Cartwright, Adrienne Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A. Barbie, Alex K. Shalek, Itay Tirosh, Peter K. Sorger, Kai W. Wucherpfennig, Eliezer M. Van Allen, Dirk Schadendorf, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Levi A. Garraway, Charles H. Yoon, Benjamin Izar, Aviv Regev
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado, Violeta Sánchez, Deon B. Doxie, Susan R. Opalenik, Anna E. Vilgelm, Emily Feld, Adam S. Johnson, Allison R. Greenplate, Melinda E. Sanders, Christine M. Lovly, Dennie T. Frederick, Mark C. Kelley, Ann Richmond, Jonathan M. Irish, Yu Shyr, Ryan J. Sullivan, Igor Puzanov, Jeffrey A. Sosman, Justin M. Balko